{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:40:08Z","timestamp":1756510808400,"version":"3.44.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"DOI":"10.7759\/cureus.91257","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:05:06Z","timestamp":1756508706000},"source":"Crossref","is-referenced-by-count":0,"title":["Carmustine Wafers (Gliadel) in Brain Metastases: Revisiting an Old Concept With New Insights"],"prefix":"10.7759","author":[{"given":"Aparna","family":"Suryadevara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninh","family":"Doan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Borak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naresh","family":"Bellam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian","family":"Hamlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae). Central Nervous System Cancers. (2024). Accessed. March 18, 2025: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1425."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nec.2010.08.007","article-title":"Epidemiology of metastatic brain tumors","volume":"22","author":"Fox BD","year":"2011","unstructured":"Fox BD, Cheung VJ, Patel AJ, Suki D, Rao G. Epidemiology of metastatic brain tumors. Neurosurg Clin N Am. 2011, 22:1-6. 10.1016\/j.nec.2010.08.007","journal-title":"Neurosurg Clin N Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan JS","year":"2004","unstructured":"Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004, 22:2865-72. 10.1200\/JCO.2004.12.149","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","author":"Schouten LJ","year":"2002","unstructured":"Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer. 2002, 94:2698-705. 10.1002\/cncr.10541","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2095","article-title":"Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control","volume":"13","author":"Ewend MG","year":"2007","unstructured":"Ewend MG, Brem S, Gilbert M, et al.. Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control. Clin Cancer Res. 2007, 13:3637-41. 10.1158\/1078-0432.CCR-06-2095","journal-title":"Clin Cancer Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.9.2752","article-title":"Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma","volume":"17","author":"O'Day SJ","year":"1999","unstructured":"O'Day SJ, Gammon G, Boasberg PD, et al.. Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma. J Clin Oncol. 1999, 17:2752-61. 10.1200\/JCO.1999.17.9.2752","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-004-0999-3","article-title":"Central nervous system metastases in women after multimodality therapy for high risk breast cancer","volume":"88","author":"Carey LA","year":"2004","unstructured":"Carey LA, Ewend MG, Metzger R, et al.. Central nervous system metastases in women after multimodality therapy for high risk breast cancer. Breast Cancer Res Treat. 2004, 88:273-80. 10.1007\/s10549-004-0999-3","journal-title":"Breast Cancer Res Treat"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/2152-7806.181987","article-title":"Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors","volume":"7","author":"Ene CI","year":"2016","unstructured":"Ene CI, Nerva JD, Morton RP, Barkley AS, Barber JK, Ko AL, Silbergeld DL. Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors. Surg Neurol Int. 2016, 7:S295-9. 10.4103\/2152-7806.181987","journal-title":"Surg Neurol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2014.08.020","article-title":"Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis","volume":"22","author":"Mu F","year":"2015","unstructured":"Mu F, Lucas JT Jr, Watts JM, et al.. Tumor resection with carmustine wafer placement as salvage therapy after local failure of radiosurgery for brain metastasis. J Clin Neurosci. 2015, 22:561-5. 10.1016\/j.jocn.2014.08.020","journal-title":"J Clin Neurosci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/5.2.79","article-title":"A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma","volume":"5","author":"Westphal M","year":"2003","unstructured":"Westphal M, Hilt DC, Bortey E, et al.. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003, 5:79-88. 10.1093\/neuonc\/5.2.79","journal-title":"Neuro Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-30","article-title":"BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors","volume":"10","author":"Reithmeier T","year":"2010","unstructured":"Reithmeier T, Graf E, Piroth T, Trippel M, Pinsker MO, Nikkhah G. BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors. BMC Cancer. 2010, 10:30. 10.1186\/1471-2407-10-30","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.17.1485","article-title":"Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial","volume":"280","author":"Patchell RA","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF, et al.. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998, 280:1485-9. 10.1001\/jama.280.17.1485","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30636-8","article-title":"Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial","volume":"18","author":"Mahajan A","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF, et al.. Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol. 2017, 18:e510. 10.1016\/S1470-2045(17)30636-8","journal-title":"Lancet Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.4610","article-title":"Comparison of local control of brain metastases with stereotactic radiosurgery vs surgical resection. A secondary analysis of a randomized clinical trial","volume":"5","author":"Churilla TM","year":"2019","unstructured":"Churilla TM, Chowdhury IH, Handorf E, et al.. Comparison of local control of brain metastases with stereotactic radiosurgery vs surgical resection. A secondary analysis of a randomized clinical trial. JAMA Oncol. 2019, 5:243-7. 10.1001\/jamaoncol.2018.4610","journal-title":"JAMA Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4137\/CMO.S7232","article-title":"Bevacizumab for the treatment of recurrent glioblastoma","volume":"5","author":"Chamberlain MC","year":"2011","unstructured":"Chamberlain MC. Bevacizumab for the treatment of recurrent glioblastoma. Clin Med Insights Oncol. 2011, 5:117-29. 10.4137\/CMO.S7232","journal-title":"Clin Med Insights Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000345668.03039.90","article-title":"Bevacizumab and chemotherapy for recurrent glioblastoma. A single-institution experience","volume":"72","author":"Nghiemphu PL","year":"2009","unstructured":"Nghiemphu PL, Liu W, Lee Y, et al.. Bevacizumab and chemotherapy for recurrent glioblastoma. A single-institution experience. Neurology. 2009, 72:1217-22. 10.1212\/01.wnl.0000345668.03039.90","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385944-carmustine-wafers-gliadel-in-brain-metastases-revisiting-an-old-concept-with-new-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:05:14Z","timestamp":1756508714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385944-carmustine-wafers-gliadel-in-brain-metastases-revisiting-an-old-concept-with-new-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.91257","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,29]]}}}